Answers are grounded in this paper and cite their sources.
Obstructive jaundice from pancreatobiliary tumors causes bacterial translocation into the liver and systemic circulation, systemic inflammatory response syndrome, multiorgan failure, and malnutrition, thereby increasing perioperative risk. Preoperative biliary drainage (PBD) aims to reverse these effects and enable safer neoadjuvant therapy and surgery. However, whether the benefits of relieving obstructive jaundice outweigh the risks of procedure-related and perioperative infectious complications remains controversial. This narrative review provides a comprehensive overview of the indications, modalities, timing, and ongoing debates regarding PBD in patients with distal and hilar biliary malignancies. In general, indications for PBD include cholangitis, severe or progressive jaundice with organ dysfunction, the need to optimize liver function for neoadjuvant therapy, and anticipated prolonged preoperative delays. In patients undergoing major hepatectomy, future liver remnant protection warrants additional consideration. Endoscopic biliary drainage is generally preferred over percutaneous transhepatic biliary drainage (PTBD) because PTBD carries a potential oncological risk and causes patient discomfort. However, PTBD remains an alternative to endoscopic drainage or as a supplementary method to drain additional effective liver volume. Fully covered self-expandable metal stents offer superior patency during the preoperative period but may increase the risks of pancreatitis, cholecystitis, and local inflammation, potentially affecting surgical complexity. Endoscopic ultrasound-guided biliary drainage shows promise but requires further validation of its safety profile and long-term oncologic outcomes. Given its distinct benefits and risks, PBD should be tailored to the patient's clinical status, treatment plan, and institutional expertise. Further studies are needed to evaluate the optimal timing of surgery, the ideal stent design, and the impact of each PBD modality on perioperative safety and long-term oncologic outcomes.
No takes yet. Share an insight, caveat, or question.
Hong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: